Jump Financial, LLC

Position in VRDN — Viridian Therapeutics, Inc.\DE

CIK 1831577 Chicago, IL

Position in VRDN

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$7,315,870

+$6,061,860 QoQ

Shares Held

398,251

+521.2% QoQ

Ownership

0.352%

of shares outstanding

% of Portfolio

0.09%

of 13F equity value

Holder Rank

#53

of 215 holders

Holding Since

Jun 2022

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Jump Financial, LLC holds $441,725,895 across 169 Biotechnology names. VRDN ranks #16 (1.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	IONS	Ionis Pharmaceuticals Inc	306,330	$24,288,904
2	VKTX	Viking Therapeutics, Inc.	579,882	$22,621,196
3	XENE	Xenon Pharmaceuticals Inc.	260,730	$15,737,662
4	CRSP	CRISPR Therapeutics AG	277,952	$15,159,500
5	BMRN	Biomarin Pharmaceutical Inc	245,390	$14,041,214
6	SRPT	Sarepta Therapeutics, Inc.	679,445	$12,209,626
7	REGN	Regeneron Pharmaceuticals, Inc.	16,242	$10,127,536
8	RARE	Ultragenyx Pharmaceutical Inc.	286,952	$9,581,327

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$7,315,870	398,251	+521.2%	Shares	Defined	2026-08-13
2026-03-31	$1,254,010	64,111	-54.8%	Shares	Defined	2026-05-14
2024-09-30	$3,229,999	141,978	+655.2%	Shares	Defined	2024-11-14
2024-06-30	$244,588	18,800	-69.5%	Shares	Defined	2024-11-14
2023-09-30	$945,771	61,654	+25.7%	Shares	Sole	2024-10-21
2023-06-30	$1,166,447	49,031	-5.2%	Shares	Sole	2024-10-21
2023-03-31	$1,316,443	51,747	+73.7%	Shares	Sole	2024-10-21
2022-12-31	$870,019	29,785	-19.5%	Shares	Sole	2023-02-14
2022-09-30	$759,177	37,015	+39.0%	Shares	Sole	2022-11-07
2022-06-30	$308,085	26,628	—	Shares	Sole	2022-08-09
No filing history on record for this holder in this stock.